GYRE · Categories · Form 4

GYRE - SEC Form 4 insider transactions

Gyre Therapeutics Inc. (GYRE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for GYRE

• 7d
  Chief Operating Officer Ye Weiguo exercised 7,500 shares at a strike of $0.75 and sold $45,680 worth of shares (7,500 units at $6.09) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 12d
  Chief Operating Officer Ye Weiguo exercised 22,220 shares at a strike of $0.75 and sold $136,653 worth of shares (22,220 units at $6.15) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 13d
  SEC Form 4 filed by Director Zhang Ping

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 14d
  Chief Operating Officer Ye Weiguo exercised 9,320 shares at a strike of $0.75 and sold $59,418 worth of shares (9,320 units at $6.38) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 16d
  Chief Operating Officer Ye Weiguo exercised 28,680 shares at a strike of $0.75 and sold $194,773 worth of shares (28,680 units at $6.79) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 26d
  Chief Executive Officer Luo Ying sold $82,927 worth of shares (10,315 units at $8.04) as part of a pre-agreed trading plan (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 27d
  SEC Form 4 filed by Large owner Gni Group Ltd.

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 27d
  SEC Form 4 filed by Chief Financial Officer Eastling Thomas Wilson

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 145d
  SEC Form 4 filed by Director Zhang Ping

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 145d
  SEC Form 4 filed by Chief Financial Officer Chen Ruoyu

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 281d
  SEC Form 4 filed by Director Weng Dan

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 299d
  SEC Form 4 filed by Director Zhang Ping

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 362d
  SEC Form 4 filed by Director Epstein David M.

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 362d
  SEC Form 4 filed by Director Eastling Thomas Wilson

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 362d
  SEC Form 4 filed by Director Nussbaum Rodney L

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 362d
  SEC Form 4 filed by Director Carmichael Gordon

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 362d
  SEC Form 4 filed by Director Parry Renate

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 370d
  President Ma Songjiang sold $26,179 worth of shares (2,558 units at $10.23) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 371d
  SEC Form 4 filed by Director Zhang Ping

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 372d
  President Ma Songjiang sold $23,804 worth of shares (2,182 units at $10.91) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 377d
  President Ma Songjiang sold $44,160 worth of shares (4,000 units at $11.04) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 379d
  President Ma Songjiang sold $44,840 worth of shares (4,000 units at $11.21) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 383d
  President Ma Songjiang sold $21,586 worth of shares (2,020 units at $10.69) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 384d
  Chief Operating Officer Ye Weiguo exercised 50,000 shares at a strike of $0.75, increasing direct ownership by 8% to 700,000 units (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 385d
  President Ma Songjiang sold $43,860 worth of shares (4,000 units at $10.96) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 404d
  Chief Operating Officer Ye Weiguo exercised 650,000 shares at a strike of $0.75 (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 411d
  Director Eastling Thomas Wilson exercised 15,000 shares at a strike of $6.93 (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 435d
  President Ma Songjiang sold $1,740 worth of shares (174 units at $10.00) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 439d
  President Ma Songjiang sold $40,440 worth of shares (4,000 units at $10.11) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 441d
  President Ma Songjiang sold $26,658 worth of shares (2,242 units at $11.89) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 443d
  President Ma Songjiang sold $48,220 worth of shares (4,000 units at $12.05) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 447d
  President Ma Songjiang sold $46,280 worth of shares (4,000 units at $11.57) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 448d
  SEC Form 4 filed by Chief Operating Officer Ye Weiguo

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 449d
  President Ma Songjiang sold $40,776 worth of shares (4,000 units at $10.19) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 453d
  President Ma Songjiang sold $43,560 worth of shares (4,000 units at $10.89) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 455d
  President Ma Songjiang sold $44,180 worth of shares (4,000 units at $11.04) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 457d
  President Ma Songjiang sold $45,480 worth of shares (4,000 units at $11.37) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 461d
  President Ma Songjiang sold $46,000 worth of shares (4,000 units at $11.50) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 463d
  President Ma Songjiang sold $45,190 worth of shares (4,000 units at $11.30) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 467d
  President Ma Songjiang sold $49,380 worth of shares (4,000 units at $12.35) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 469d
  President Ma Songjiang sold $48,860 worth of shares (4,000 units at $12.21) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 474d
  President Ma Songjiang sold $46,360 worth of shares (4,000 units at $11.59) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 475d
  President Ma Songjiang sold $45,435 worth of shares (3,878 units at $11.72) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 477d
  President Ma Songjiang sold $50,020 worth of shares (4,000 units at $12.51) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 482d
  President Ma Songjiang sold $48,029 worth of shares (4,000 units at $12.01) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 484d
  President Ma Songjiang sold $45,960 worth of shares (4,000 units at $11.49) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 488d
  President Ma Songjiang sold $45,600 worth of shares (4,000 units at $11.40) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 490d
  President Ma Songjiang sold $45,380 worth of shares (4,000 units at $11.35) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 492d
  President Ma Songjiang sold $42,760 worth of shares (4,000 units at $10.69) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 495d
  President Ma Songjiang sold $42,960 worth of shares (4,000 units at $10.74) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 498d
  President Ma Songjiang sold $42,860 worth of shares (4,000 units at $10.71) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 503d
  President Ma Songjiang sold $42,480 worth of shares (4,000 units at $10.62) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 505d
  President Ma Songjiang sold $11,157 worth of shares (1,113 units at $10.02) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 509d
  Amendment: President Ma Songjiang sold $9,871 worth of shares (833 units at $11.85) (SEC Form 4)

  4/A - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 511d
  President Ma Songjiang sold $22,336 worth of shares (2,216 units at $10.08) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 512d
  SEC Form 4 filed by Director Zhang Ping

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 513d
  President Ma Songjiang sold $47,543 worth of shares (4,000 units at $11.89) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 517d
  President Ma Songjiang sold $49,600 worth of shares (4,000 units at $12.40) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 520d
  President Ma Songjiang sold $50,553 worth of shares (4,000 units at $12.64) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
• 524d
  President Ma Songjiang sold $48,399 worth of shares (4,000 units at $12.10) (SEC Form 4)

  4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)

Other GYRE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends